The FDA (CBER) has cleared the ASi Manager-AT as the first and only method for the interpretation and screening for in vitro diagnostics, blood donor and cadaveric (non-heart beating) donor screening. 


The ASiManager-AT™ is a integrated digital particle analyzer that objectively interprets the ASI RPR Card Test for Syphilis. The Analyzer utilizes the proprietary ASI Agglutination Serology Interpretation software and ASI reagents.


Laboratories can now follow the CDC recommended nontreponemal algorithm (RPR/VDRL) while providing objective, standardized test interpretation and realize the benefits of automation and data management.

  • Objective and standardized interpretation

  • Data management

  • Utilizes ASI RPR Card Test for Syphilis

  • Easy-to-use

  • Cost effective

  • Lowest cost per test

  • Increased reliability

  • Optimize Labor Resources

  • Workflow Improvement

  • Network/LIMS capable

  • Laboratory proven

  • Results providers know and trust

  • Throughput- 450 samples/hour

  • FDA 510(k) Cleared for in vitro diagnostic and blood donor and cadaveric screening

Sensitivity: >97.99%

Specificity: >99.7%

Independent Testing Results: 

Translab (M) Sdn Bhd
Translab (M) Sdn Bhd is committed to be a Preferred Premium Supplier and Service Provider for Medical & Diagnostics, Laboratories, Life Science, Law Enforcement, Safety & Security and General Scientific Equipment & Devices.

Find Us At
18 Jalan PJS 11/16, Bandar Sunway, 46150 Petaling Jaya, Selangor, Malaysia.
+(60)3 5636 2116
+(60)3 5633 4118
+(60)12 366 8346
+(60)12 373 2867
Quick Links
Related Links

© 2020 by Translab. All Rights Reserved.   |  Terms of Use  |   Privacy Policy  |  Disclaimer